|
| << vorige | volgende >> |
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
Details van artikel 37 van 55 gevonden artikelen
| Titel: |
Prices and access to essential medicines |
| Auteur: |
Carl-Erik Schulz |
| Verschenen in: |
International journal of risk & safety in medicine |
| Paginering: | Jaargang 13 (2001) nr. 2-3 pagina's 143-151 |
| Jaar: |
2001-04-01 |
| Inhoud: |
Patent rights establish a price level for medicines that makes them unaffordable for the majority of the people in the world. This paper presents some main consequences of the influence of patents on the markets for drugs, and provides some economic arguments that might be useful in the discussion of patent rights. Patents for essential medicines have unacceptable social short run effects. Arguments that in the long run they provide incentives to promote invention seem uncertain and poorly justified. A system of compulsory licensing inside the WTO TRIPS agreement will work better. The paper is not the result of original research by the author, but it attempts to assist in understanding certain of the economic arguments which are advanced in favour of patent rights, and to consider how such rights influence consumers of medicines. |
| Uitgever: |
IOS Press |
| Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
Details van artikel 37 van 55 gevonden artikelen
| << vorige | volgende >> |